Anticonvulsant effects of neurotropin

Department of Normal Physiology, N. I. Pirogov Odessa Medical Institute. Department of Normal Physiology, I. M. Sechenov First Moscow Medical Institute. Laboratory of General Pathology of the Nervous System, Research Institute of General Pathology and Pathophysiology, Academy of Medical Sciences of the USSR, Moscow. Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 111, No. 1, pp. 49–52, January, 1991.     

Effect of neurotropin on seizure activity in picrotoxin kindling

Department of Normal Physiology, N. I. Pirogov Odessa Medical Institute. (Presented by Academician of the Academy of Medical Sciences of the USSR G. N. Kryzhanovskii.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 113, No. 3, pp. 236–239, March, 1992.     

Reflex sympathetic dystrophy in childhood: A case report

A case report is presented of a 15-year-old girl with reflex sympathetic dystrophy (RSD). She was referred to hospital because of left upper limb pain. Her left upper limb was cold, edematous and blue with a limited active range of movement. The serum concentration of noradrenaline was lower on the painful side than on the healthy side, and neurotropin, which has an antinociceptive effect to hyperalgesia, was clearly effective. Early diagnosis and management is essential in the treatment of RSD and administration of neurotropin is a useful and non-invasive treatment without severe adverse effects.     

神经妥乐平治疗周围神经病变的疗效观察

目的：观察神经妥乐平治疗周围神经病变的临床效果。方法：静脉滴注神经妥乐平，比较用药前后患者神经系统症状及神经传导速度的变化。结果：治疗后患者视觉模拟评分下降，患侧肢体神经传导速度改善。治疗前后比较，有显著性差异。结论：对多种疾病导致的周围神经病患者，使用神经妥乐平治疗可获得较好疗效。     

药品行政保护品种介绍:神经系统与精神药物(五)(续完)

神经妥乐平片剂通用名:牛痘免疫病毒疫苗接种家兔炎症皮肤组织提取物片剂.商品名:神经妥乐平(Neurotropin)片剂.     

Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats

Summary Neurotrophin-3 (NT-3) acts as a target-derived neurotrophic factor for large calibre sensory neurones and plays a role in the maintenance of the adult phenotype of proprioceptive and mechanoreceptive fibres. Large fibre sensory neuropathy is common in diabetes mellitus and the aim of this study was to determine whether endogenous NT-3-dependent neurotrophic support was sub-optimal in the streptozotocin-diabetic rat. NT-3 gene expression was analysed by Northern blotting and ELISA in hindlimb skeletal muscle and found to be decreased by up to 70 % (p < 0.05) in rats with 4–6 weeks of diabetes compared to aged-matched controls. Treatment of other diabetic rats with insulin prevented development of deficits of both NT-3 protein and of its mRNA. The deficits in target tissue production of NT-3 were coincident with significant decreases in its anterograde and retrograde axonal transport in sciatic nerve at 6 weeks of diabetes. The mRNA expression in lumbar dorsal root ganglia of the specific receptor for NT-3, trkC, was also down-regulated at 12 weeks of diabetes by 50 % (p < 0.05). The observed decreases in NT-3 target tissue production and related axonal transport suggest that large calibre sensory neurones expressing trkC may be receiving sub-optimal neurotrophic support in experimental diabetes. [Diabetologia (1998) 41: 300–306] Received: 12 August 1997 and in revised form: 7 November 1997     

神经妥乐平治疗老年退变性颈椎病和腰椎管狭窄症的成本-效果分析

目的:探讨不同药物治疗方案治疗老年退变性颈椎病和腰椎管狭窄症的经济效果.方法: 87例患者根据药物剂型、剂量和用药时间分为 3组, A组为口服神经妥乐平片 8 U, 2次 /d, 28 d后停药; B组为口服神经妥乐平片 8 U, 2次 /d, 14 d后停药; C组为静脉滴注神经妥乐平注射液 7.2 U, 1次 /d, 14 d后停药.结果: A, B, C组治疗成本( C)分别为 1 876.00, 938.00, 1 616.58元;总有效率( E%)分别为 76.00%, 66.67%, 90.32%;单位效果所需成本( C/E)分别为 24.68, 14.07元, 17.90元.在 B组的基础上, A组和 C组增加单位效果所需成本(△ C/△ E)分别为 100.54, 28.69元.结论: C组较 B组的总有效率有较大提高,而且获得单位效果所需成本明显低于 A组,故为较合理的用药方案.     

神经妥乐平对痛性糖尿病神经病变的治疗作用

目的:以安慰剂为对照,观察神经妥乐平治疗痛性2型糖尿病神经病变的疗效。方法: 2型糖尿病神经病变病人40例,随机分为治疗组和对照组,各20例。分别静脉注射神经妥乐平或氯化钠注射液3mL,qd, 2wk,再口服神经妥乐平片剂或安慰剂(淀粉压片) 2片,bid, 10wk。比较治疗前后血糖、自发性神经痛、麻木、四肢神经传导速度、四肢末梢感觉定量等指标的改变。结果:治疗2wk,治疗组自发性神经痛有明显改善,视觉类比量表(VAS)评分下降(3. 9±s1. 3)分,P<0. 01;对照组无明显改变, 2组比较有显著差异,P<0. 01。疗程结束,治疗组自发性神经痛进一步减轻,VAS评分下降(5. 4±1. 4)分,降低幅度高于对照组( 2. 5±1. 4 )分,有73 % (11 /15 )的病人疼痛得到控制。67 %(10 /15)的病人麻木症状改善,疗效优于对照组,P<0. 01。四肢神经传导速度改变不明显,冷、热、振动觉得到不同程度的改善或延缓降低。治疗过程中未出现明显不良反应。结论:神经妥乐平对2型糖尿病神经损害的自发性疼痛有较好的疗效,对冷、热、振动感觉恢复有一定的作用。     

Changes in unit activity of hippocampal area CA3 due to the neuroimmunomodulator neurotropin

P. K. Anokhin Research Institute of Normal Physiology, Academy of Medical Sciences of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR K. V. Sudakov.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 113, No. 3, pp. 227–230, March, 1992.     

射频热凝联合牛痘疫苗接种家兔炎症皮肤提取物治疗带状疱疹后遗神经痛

目的:观察射频热凝联合牛痘疫苗接种家兔炎症皮肤提取物(神经妥乐平)治疗带状疱疹后遗神经痛的疗效.方法:将90例胸腰部带状疱疹后遗神经痛(post-herpetic neuralgia,PHN)患者随机分为射频热凝(radiofrequency thermocoagulation,RFT)联合神经妥乐平组(A组,30例)、射频热凝组(B组,30例)、神经妥乐平组(C组,30例),采用视觉模拟评估法(vasual analogue scale,VAS),分别对治疗前、后VAS评分进行统计分析.结果:治疗后VAS比较,A组与B、c两组比较,有统计学意义(P<0.01);治疗后疗效比较,A组与B、c两组比较,有统计学意义(P<0.05、P<0.01).结论:射频热凝联合神经妥乐平有效缓解带状疱疹后遗神经痛,疗效明显优于单纯射频和单纯使用神经妥乐平.